PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $255.43 | +0.2% | +11.1% | +25.2% | +50.3% | +117.6% | +95.2% | +46.3% | |
| TTM Revenue | $4.44B | +4.0% | – | +4.0% | – | +9.2% | +18.7% | +82.2% | |
| TTM EPS | -$0.02 | +99.7% | – | +99.7% | – | -100.3% | +99.3% | -100.2% | |
| 3.54 | +0.3% | +11.0% | +25.5% | +46.3% | +84.4% | +50.6% | +37.2% | ||
| 3.61 | +0.3% | +10.7% | +25.4% | +47.4% | +107.5% | +64.1% | -11.1% | ||
| $18.57B | +0.2% | +9.3% | +21.1% | +38.3% | +70.7% | +45.8% | +11.2% | ||
| 11.89 | +0.2% | +9.3% | +21.1% | +12.9% | +40.5% | +8.7% | -28.7% | ||
| Market Cap | $16B | +0.2% | +10.9% | +25.2% | +53.5% | +125.2% | +93.2% | +50.2% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | 225.65 | N/A | |
| 5Y | 225.65 | N/A | |
| All | 425.65 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | 13.19 | N/A | |
| 5Y | 13.19 | N/A | |
| All | 9.64 | N/A |
History
Formula
Data Sources & References
- JAZZ Official Website www.jazzpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1232524/000123252426000013/0001232524-26-000013-index.htm
- JAZZ Profile on Yahoo Finance finance.yahoo.com/quote/JAZZ
- JAZZ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jazz